Amnuaiphon Waraya, Anuwatnonthakate Amornrat, Nuyongphak Prungsri, Sinthuwatanawibool Chalinthorn, Rujiwongsakorn Sadudee, Nakara Prapa, Komsakorn Sitijate, Wattanaamornkiet Wanpen, Moolphate Saiyud, Chiengsorn Navarat, Kaewsaard Samroui, Nateniyom Sriprapa, Varma Jay K
Vachira Phuket Hospital, Thailand.
Trop Med Int Health. 2009 Nov;14(11):1338-46. doi: 10.1111/j.1365-3156.2009.02376.x. Epub 2009 Sep 4.
In countries with both TB and human immunodeficiency virus (HIV) epidemics, HIV is known to be the most powerful risk factor for death during tuberculosis (TB) treatment. Few recent studies have evaluated risk factors for death among HIV-uninfected TB patients in these countries. We analysed data from a multi-province demonstration project in Thailand to answer this question.
We prospectively collected data from HIV-uninfected TB patients treated for TB in four provinces and the national infectious diseases hospital in Thailand from 2004-2006. Standard WHO definitions were used to classify treatment outcomes. We used log-binomial multivariate regression to calculate adjusted relative risk (aRR) and 95% confidence intervals (CI) for factors associated with death.
Of 5318 cases, 441 (8%) died during TB treatment. The mean age was 47 years (range 8 months-97 years). Multidrug-resistant (MDR)-TB was diagnosed in 62 (1%). In multivariate analysis, patients older than 44 years were significantly more likely to die than patients aged 15-44 years [age 45-64, aRR 2.9 (CI 2.2-3.8)] [age > 64 years, aRR 5.0 (CI 3.9-6.6)]. Other independent risk factors for death included Thai nationality [aRR 3.9 (CI 1.6-9.5)], MDR-TB [aRR 2.8 (CI 1.7-4.8)], not being married [aRR 1.4 (CI 1.2-1.7)], and living in Chiang Rai province [aRR 2.7 (CI 1.7-4.4)].
The death rate was high among HIV-uninfected TB patients in Thailand. Efforts to improve TB diagnosis and treatment in the elderly and to improve MDR-TB treatment may help reduce mortality.
在结核病(TB)和人类免疫缺陷病毒(HIV)均流行的国家,HIV是已知的结核病治疗期间死亡的最强大风险因素。最近很少有研究评估这些国家未感染HIV的结核病患者的死亡风险因素。我们分析了泰国一个多省份示范项目的数据来回答这个问题。
我们前瞻性地收集了2004年至2006年在泰国四个省份以及国家传染病医院接受结核病治疗的未感染HIV的结核病患者的数据。采用世界卫生组织的标准定义对治疗结果进行分类。我们使用对数二项式多变量回归来计算与死亡相关因素的调整相对风险(aRR)和95%置信区间(CI)。
在5318例病例中,441例(8%)在结核病治疗期间死亡。平均年龄为47岁(范围8个月至97岁)。62例(1%)被诊断为耐多药(MDR)结核病。在多变量分析中,44岁以上的患者比15至44岁的患者死亡可能性显著更高[45至64岁,aRR 2.9(CI 2.2至3.8)][64岁以上,aRR 5.0(CI 3.9至6.6)]。其他独立的死亡风险因素包括泰国国籍[aRR 3.9(CI 1.6至9.5)]、MDR结核病[aRR 2.8(CI 1.7至4.8)]、未婚[aRR 1.4(CI 1.2至1.7)]以及居住在清莱府[aRR 2.7(CI 1.7至4.4)]。
泰国未感染HIV的结核病患者死亡率较高。改善老年人结核病诊断和治疗以及改善MDR结核病治疗的努力可能有助于降低死亡率。